Harnessing radiotherapy-induced NK-cell activity by combining DNA damage-response inhibition and immune checkpoint blockade.
Emmanuel C PatinMagnus T DillonPablo NenclaresLorna GroveHeba SolimanIsla LeslieDavina NorthcoteGalabina BozhanovaEva Crespo-RodriguezHolly BaldockHarriet WhittockGabriella BakerJoan KyulaJeane GuevaraAlan A MelcherJames HarperHormas GhadiallySimon SmithMalin PedersenMartin McLaughlinKevin J HarringtonPublished in: Journal for immunotherapy of cancer (2022)
This work delineates a previously unrecognized role for NK cells in the antitumor immune response to radiotherapy that can be augmented by small-molecule DNA damage-response inhibitors and immune checkpoint blockade.